Pediatric Oncology | Specialty

The OncLive Pediatric Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of cancers in pediatric patients, including acute lymphoblastic leukemia, acute myeloid leukemia, brain cancers, sarcomas, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in childhood and adolescent and young adult cancers.

Survivors of Childhood Cancers Living Longer Due to Improvements in Care and Follow-up

May 31st 2015

Over the past 30 years, survivors of childhood cancers have become less likely to die of illnesses caused by their treatment, such as new malignancies or cardiac or lung disease.

Intensified Chemotherapy Extends EFS for Children With Wilms Tumor

May 13th 2015

Treatment with an intensified chemotherapy regimen was associated with improvements in event-free survival for children with favorable histology Wilms tumor with loss of heterozygosity in chromosomes 1p and 16q.

CAR T-Cell Therapy Surpasses 90% Complete Remission Rate in Pediatric ALL

April 24th 2015

The chimeric antigen receptor T-cell therapy JCAR017 elicited a 91% complete remission rate in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Three FDA Approvals, NCI Director Resigns, and More

March 12th 2015

FDA Approves Dinutuximab for High-Risk Neuroblastoma

March 10th 2015

The FDA has approved dinutuximab in combination with interleukin-2, GM-CSF, and 13-cis-retinoic acid as a frontline therapy for pediatric patients with high-risk neuroblastoma.

Final Thoughts on AML and ALL

January 9th 2015

New Treatments in Acute Myeloid Leukemia

January 9th 2015

Role of Transplant in Acute Myeloid Leukemia

January 9th 2015

Therapeutic Targets in Acute Lymphoblastic Leukemia

January 9th 2015

CAR-Modified T Cell Therapy in ALL

January 9th 2015

Blinatumomab in Acute Lymphoblastic Leukemia

January 9th 2015

Minimum Residual Disease in ALL

January 9th 2015

Asparaginase in Acute Lymphoblastic Leukemia

January 9th 2015

Chemotherapy Regimens in Patients With ALL

January 9th 2015

TKIs in Philadelphia Chromosome-Positive ALL

January 9th 2015

Vincristine in Acute Lymphoblastic Leukemia

January 9th 2015

Identifying Transplant Candidates in ALL

January 9th 2015

Induction Therapy in Adult Ph-negative ALL

January 9th 2015

Introduction: Understanding ALL and Its Prognostic Factors

January 9th 2015

Aprepitant Yields Significant Benefits for the Prevention of CINV in Children

June 28th 2014

Aprepitant is significantly more effective than a comparator placebo-added regimen in preventing CINV in children, with benefits seen across all phases of treatment.